Sunshine Biopharma Stock Market Value
| SBFM Stock | USD 2.36 0.24 11.32% |
| Symbol | Sunshine |
Sunshine Biopharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (127.90) | Revenue Per Share 197.42 | Quarterly Revenue Growth 0.416 | Return On Assets (0.11) | Return On Equity (0.18) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sunshine Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sunshine Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sunshine Biopharma.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Sunshine Biopharma on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Sunshine Biopharma or generate 0.0% return on investment in Sunshine Biopharma over 30 days. Sunshine Biopharma is related to or competes with Neurosense Therapeutics. Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development o... More
Sunshine Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sunshine Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sunshine Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 19.65 | |||
| Value At Risk | (6.29) | |||
| Potential Upside | 5.9 |
Sunshine Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sunshine Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sunshine Biopharma's standard deviation. In reality, there are many statistical measures that can use Sunshine Biopharma historical prices to predict the future Sunshine Biopharma's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.55) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.72) |
Sunshine Biopharma Backtested Returns
Sunshine Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0713, which indicates the firm had a -0.0713% return per unit of risk over the last 3 months. Sunshine Biopharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sunshine Biopharma's Variance of 12.71, coefficient of variation of (755.24), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. The entity has a beta of 0.67, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sunshine Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sunshine Biopharma is expected to be smaller as well. At this point, Sunshine Biopharma has a negative expected return of -0.27%. Please make sure to validate Sunshine Biopharma's skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Sunshine Biopharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.80 |
Very good predictability
Sunshine Biopharma has very good predictability. Overlapping area represents the amount of predictability between Sunshine Biopharma time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sunshine Biopharma price movement. The serial correlation of 0.8 indicates that around 80.0% of current Sunshine Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.8 | |
| Spearman Rank Test | 0.9 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Sunshine Biopharma lagged returns against current returns
Autocorrelation, which is Sunshine Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sunshine Biopharma's stock expected returns. We can calculate the autocorrelation of Sunshine Biopharma returns to help us make a trade decision. For example, suppose you find that Sunshine Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sunshine Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sunshine Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sunshine Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sunshine Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Sunshine Biopharma Lagged Returns
When evaluating Sunshine Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sunshine Biopharma stock have on its future price. Sunshine Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sunshine Biopharma autocorrelation shows the relationship between Sunshine Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Sunshine Biopharma.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Sunshine Biopharma Correlation, Sunshine Biopharma Volatility and Sunshine Biopharma Alpha and Beta module to complement your research on Sunshine Biopharma. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Sunshine Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.